Does the preoperative alpha-fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function?

Hepatology Research

Volumn 44, Issue 14, 2014, Pages E437-E446

  Kudo, Atsushi ^a   Matsumura, Satoshi ^a   Ban, Daisuke ^a   Irie, Takumi ^a   Ochiai, Takanori ^a   Tanaka, Shinji ^a   Arii, Shigeki ^a   Tanabe, Minoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Alpha fetoprotein; Liver function; Microvascular invasion; Normal liver function; Prognosis

Indexed keywords

EID: 84917727885     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12335     Document Type: Article

References (45)

1. Kudo A, Mogushi K, Takayama T etal. Mitochondrial metabolism in the noncancerous liver determine the occurrence of hepatocellular carcinoma: a prospective study. J Gastroenterol 2013; [Epub ahead of print].
2. Toyoda H, Kumada T, Kaneoka Y etal. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC. J Hepatol 2008; 49: 223-232.
3. Kim HS, Park JW, Jang JS etal. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study. J Clin Gastroenterol 2009; 43: 482-488.
4. Kiriyama S, Uchiyama K, Ueno M etal. Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival. Ann Surg 2011; 254: 984-991.
5. Shim JH, Yoon DL, Han S etal. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis. Ann Surg Oncol 2012; 19: 3687-3696.
6. Okuda H, Nakanishi T, Takatsu K etal. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity. Cancer 1999; 85: 812-818.
7. Gotoh M, Nakatani T, Masuda T etal. Prediction of invasive activities in hepatocellular carcinomas with special reference to alpha-fetoprotein and des-gamma-carboxyprothrombin. Jpn J Clin Oncol 2003; 33: 522-526.
8. Trevisani F, D'Intino PE, Morselli-Labate AM etal. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001; 34: 570-575.
9. Yamashita Y, Taketomi A, Itoh S etal. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 2007; 205: 19-26.
10. Shi M, Zhang CQ, Zhang YQ, Liang XM, Li JQ. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg 2004; 28: 376-381.
11. Shindoh J, Hasegawa K, Inoue Y etal. Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma. HPB (Oxford) 2013; 15: 31-39.
12. Aragon RJ, Solomon NL. Techniques of hepatic resection. J Gastrointest Oncol 2012; 3: 28-40.
13. Chen J, Huang K, Wu J etal. Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci 2011; 56: 1626-1633.
14. Kudo A, Tanaka S, Ban D etal. Anatomic resection reduces the recurrence of solitary hepatocellular carcinoma
15. Rodriguez-Peralvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol 2013; 20: 325-339.
16. Lee YH, Hsu CY, Huang YH etal. alpha-Fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma. J Gastrointest Surg 2012; 17: 730-738.
17. Sumie S, Kuromatsu R, Okuda K etal. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008; 15: 1375-1382.
18. Wang CC, Iyer SG, Low JK etal. Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2009; 16: 1832-1842.
19. Bhangui P, Vibert E, Majno P etal. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology 2011; 53: 1570-1579.
20. Mazzaferro V, Llovet JM, Miceli R etal. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43.
21. Sato K, Tanaka S, Mitsunori Y etal. Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma; clinical and biological significance. Hepatology 2012; 57: 1436-1447.
22. Mitsunori Y, Tanaka S, Nakamura N etal. Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact. J Hepatobiliary Pancreat Sci 2012; 20: 234-242.
23. Wai CT, Greenson JK, Fontana RJ etal. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526.
24. Yin J, Tian L. Joint confidence region estimation for area under ROC curve and Youden index. Stat Med 2014; 33: 985-1000.
25. Duvoux C, Roudot-Thoraval F, Decaens T etal. Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria. Gastroenterology 2012; 143: 986-94.e3; quiz e14-15.
26. Muscari F, Guinard JP, Kamar N, Peron JM, Otal P, Suc B. Impact of preoperative alpha-fetoprotein level on disease-free survival after liver transplantation for hepatocellular carcinoma. World J Surg 2012; 36: 1824-1831.
27. Mailey B, Artinyan A, Khalili J etal. Evaluation of absolute serum alpha-fetoprotein levels in liver transplant for hepatocellular cancer. Arch Surg 2011; 146: 26-33.
28. Todo S, Furukawa H, Tada M. Extending indication: role of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2007; 13: S48-54.
29. Mazzaferro V, Regalia E, Doci R etal. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
30. Murakata A, Tanaka S, Mogushi K etal. Gene expression signature of the gross morphology in hepatocellular carcinoma. Ann Surg 2011; 253: 94-100.
31. Trzpis M, McLaughlin PM, de Leij LM, Harmsen MC. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am J Pathol 2007; 171: 386-395.
32. Nagrath S, Sequist LV, Maheswaran S etal. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007; 450: 1235-1239.
33. Fujiki M, Takada Y, Ogura Y etal. Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma. Am J Transplant 2009; 9: 2362-2371.
34. Bertino G, Neri S, Bruno CM etal. Diagnostic and prognostic value of alpha-fetoprotein, des-gamma-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma. Minerva Med 2011; 102: 363-371.
35. Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 2002; 131: 311-317.
36. Wakai T, Shirai Y, Sakata J etal. Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol 2007; 14: 1356-1365.
37. Hasegawa K, Kokudo N, Imamura H etal. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005; 242: 252-259.
38. Chan SC, Fan ST, Chok KS etal. Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion. Hepatol Int 2011; [Epub ahead of print].
39. Lim KC, Chow PK, Allen JC etal. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg 2011; 254: 108-113.
40. Lauwers GY, Terris B, Balis UJ etal. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol 2002; 26: 25-34.
41. Cucchetti A, Cescon M, Ercolani G, Bigonzi E, Torzilli G, Pinna AD. A comprehensive meta-regression analysis on outcome of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Ann Surg Oncol 2012; 19: 3697-3705.
42. Zhou Y, Xu D, Wu L, Li B. Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Langenbecks Arch Surg 2011; 396: 1109-1117.
43. Kudo A, Tanaka S, Ban D etal. Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis. J Gastroenterol 2013; [Epub ahead of print].
44. Eguchi S, Kanematsu T, Arii S etal. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 2008; 143: 469-475.
45. Schiodt FV, Ostapowicz G, Murray N etal. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl 2006; 12: 1776-1781.